|
2024
|
Invention
|
Fosnetupitant for administration via intravenous bolus. Improved methods of administering neuroki... |
|
|
Invention
|
Crystalline forms of an nk-1 antagonist.
The present invention is related to crystalline forms o... |
|
|
Invention
|
New centrally-active ghrelin agonist and medical uses thereof.
The new compound 3-(1-(2,3-dichlo... |
|
2023
|
Invention
|
Liquid oral formulations of netupitant and palonosetron. Orally administered liquid formulations ... |
|
|
Invention
|
Medical treatments based on anamorelin.
Methods of treating cancer related conditions using anam... |
|
2022
|
Invention
|
Compositions and methods for treating centrally mediated nausea and vomiting. Provided are compos... |
|
|
Invention
|
Physiologically balanced injectable formulations of fosnetupitant. Injectable dosages and formula... |
|
|
Invention
|
Methods of determining and providing clinically meaningful improvements on patient reported outco... |
|
|
G/S
|
advice to patients regarding business administration of pharmacy reimbursement programs financial... |
|
|
Invention
|
Use of anamorelin to treat cancer-related fatigue. Methods of using anamorelin to treat fatigue a... |
|
|
Invention
|
Use of anamorelin to treat cancer-related fatigue.
Methods of using anamorelin to treat fatigue ... |
|
|
Invention
|
Piperidine urea derivatives for use as inotropic agents.
The invention concerns the use of compo... |
|
|
Invention
|
Piperidine urea derivatives for use as inotropic agents. The invention concerns the use of compou... |
|
|
G/S
|
Pharmaceutical preparations and substances for cancer
treatment. |
|
|
G/S
|
Préparations et substances pharmaceutiques pour le traitement du cancer. |
|
|
Invention
|
Process for the synthesis of substituted chloromethyl dialkylphosphates. Disclosed are compounds ... |
|
|
Invention
|
Fumarate salt of (r)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-... |
|
2021
|
Invention
|
Methods of using 4-amino-n-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholinoprop-... |
|
|
Invention
|
Crystalline forms of 4-amino-n-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholinop... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cachexia and cancer-associated anorexia, weight ... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment
of cancer and skeletal abnormalitie... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of cancer. |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-inflammatory
drugs, anti-emetic drugs, drugs for the t... |
|
|
G/S
|
Préparations pharmaceutiques pour le traitement de lymphomes, de lymphomes non hodgkiniens, de ly... |
|
|
Invention
|
Crystalline forms of an nk-1 antagonist. The present invention is related to crystalline forms of... |
|
2020
|
Invention
|
Medical treatments based on anamorelin. Methods of treating cancer related conditions using anamo... |
|
|
G/S
|
Organisation of conferences and symposia in the field of medical science and specifically CINV (c... |
|
|
G/S
|
Pharmaceutical preparations, namely antiemetic preparations. |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of cancer |
|
|
Invention
|
Methods of manufacturing anamorelin tablets having improved stability.
Methods for reducing the ... |
|
|
Invention
|
Methods of manufacturing anamorelin tablets having improved stability. Methods for reducing the f... |
|
|
G/S
|
Préparations pharmaceutiques utilisées en oncologie; anticancéreux. |
|
|
G/S
|
Pharmaceutical preparations for use in oncology; anti-cancer
compounds. |
|
|
G/S
|
pharmaceutical preparations for use in oncology; anti-cancer preparations. |
|
|
Invention
|
Fosnetupitant chloride hydrochloride having improved stability. Fosnetupitant chloride hydrochlor... |
|
|
G/S
|
Pharmaceutical products, medical and veterinary
preparations; sanitary products for medical purp... |
|
|
G/S
|
Pharmaceutical products, namely, anti-inflammatory drugs, anti-emetic drugs, drugs for the treatm... |
|
|
Invention
|
Continuous process for producing benzimidazole derivatives. Disclosed are continuous processes fo... |
|
|
Invention
|
Methods of producing anamorelin hydrochloride having controlled chloride content. The present inv... |
|
|
Invention
|
Substituted asymmetric ureas as modulators of ghrelin receptor activity.
Disclosed are compounds... |
|
2019
|
G/S
|
Custom manufacture of pharmaceutical products per customer order and in accordance with customer ... |
|
|
G/S
|
Pharmaceutical products; chemical preparations for medical
use; chemical preparations for pharma... |
|
|
G/S
|
pharmaceuticals; chemical preparations for medical purposes; chemical preparations for pharmaceut... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of lymphoma, non-Hodgkin's lymphoma, cutaneous T-ce... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of lymphoma,
non-Hodgkin's lymphoma, cutaneous T-c... |
|
|
Invention
|
Centrally-active ghrelin agonist and medical uses thereof. The new compound 3-(1-(2,3-dichloro-4-... |
|
|
Invention
|
New centrally-active ghrelin agonist and medical uses thereof. The new compound 3-(1-(2,3-dichlor... |
|
|
G/S
|
Pharmaceutical preparations. Downloadable application software. |
|
|
G/S
|
downloadable application software for monitoring and managing the side effects of pharmacological... |
|
2018
|
Invention
|
Substituted piperaziniums for the treatment of emesis. 1) receptor. The compounds have the genera... |
|
|
G/S
|
Pharmaceutical preparations namely anti-cachexia and anti-metabolic disturbances drugs, namely an... |
|
|
Invention
|
Fumarate salt of (r)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2- trifluoroethyl)-1-methyl-1... |
|
|
Invention
|
Crystalline forms of fosnetupitant.
The present invention provides crystalline forms of the chlo... |
|
|
Invention
|
Substituted asymmetric ureas as modulators of ghrelin receptor activity. Disclosed are compounds,... |
|
|
G/S
|
Pharmaceutical preparations and substances for the treatment of ulcerative and inflammatory condi... |
|
|
Invention
|
Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-n... |
|
2017
|
Invention
|
Therapeutic uses of elsiglutide.
The invention relates to therapeutic uses of elsiglutide, parti... |
|
|
Invention
|
Asymmetric ureas and medical uses thereof. Disclosed are compounds, compositions and methods for ... |
|
|
G/S
|
Medicated and non-medicated preparations in the form of
tablets, mucoadhesive tablets, compresse... |
|
|
G/S
|
Pharmaceutical products, veterinary products; sanitary
products for medical purposes; dietetic s... |
|
|
G/S
|
Treatment and transformation of chemical, biochemical and pharmaceutical products during the manu... |
|
|
Invention
|
Physiologically balanced injectable formulations of fosnetupitant. Injectable dosages and f... |
|
|
G/S
|
Medicated preparations and food supplements in the form of
tablets, muco-adhesive tablets, compr... |
|
|
G/S
|
Pharmaceutical preparations, namely, antiemetic drugs, anti-emetic, anti-tumor and anticancer pha... |
|
2016
|
G/S
|
pharmaceutical preparations for the prevention and treatment of chemotherapy and radiotherapy sid... |
|
|
G/S
|
Medicated and non-medicated preparations in the form of tablets, mucoadhesive tablets, compressed... |
|
|
G/S
|
Food supplements consisting of cranberry extract for the prevention of urinary tract infections a... |
|
|
G/S
|
Scientific research for medical purposes in the area of cancerous diseases |
|
|
G/S
|
Pharmaceutical preparations and compositions for the treatment and prevention of cancer; biologic... |
|
|
G/S
|
Chemical substances, chemical materials and chemical
products. Pharmaceutical products, veterina... |
|
|
G/S
|
Treatment in the nature of chemical processing of chemical, biochemical and pharmaceutical produc... |
|
|
G/S
|
Integrative, cancer supportive and palliative care products; food supplements; food supplements f... |
|
|
G/S
|
Chemical substances, chemical materials and chemical preparations. Pharmaceutical and veterinary ... |
|
|
G/S
|
Anti-emetic drugs |
|
|
G/S
|
Pharmaceutical products, medical and veterinary
preparations; medicines; pharmaceutical preparat... |
|
|
G/S
|
Nutritional supplements, to the exception of nutritional supplements for pregnant women; dietetic... |
|
|
G/S
|
Nutritional supplements; dietetic foods adapted for medical purposes; medicinal herbs; food suppl... |
